2005Practical Journal of Medicine & PharmacyRequires access

Construction and expression of a site-specific mutant of human interleukin-2 gene in E.coli

Cheng Zheng

Open publisher page 0 citations

Abstract

Objective To construct expression clones of a site-specific mutagenesis(88N→R) of human interleukin-2(IL-2) gene to further investigate new kind of hIL-2 gene agent in clinical trial. Methods The human interleukin-2 cDNA containing full-length of encoding region was cloned by RT-PCR and confirmed by DNA sequencing. With recombinant PCR, authors amplified the whole genes of IL-2 with the site-directed mutagenesis and confirmed by DNA sequencing again, then cloned to the procaryotic expressive vector pGEX-4T-2 and transformated to E.coli.DH5 IL-2 recombinant clone was induced by IPTG to express the allosteric IL-2 proteins and the products were identified by SDS-PAGEPAGE.Results The mutated IL-2 gene clone was obtained successfully, while the recom-binant IL-2 proteins were efficiently expressed in E.coli DH5 Human IL-2 cDNA with the site-directed mutagenesis were expressed in E.coli, which has provided useful information for development of low-toxic, high-efficiency IL-2 recombinant agent.

About this research paper

What this paper is about

Objective To construct expression clones of a site-specific mutagenesis(88N→R) of human interleukin-2(IL-2) gene to further investigate new kind of hIL-2 gene agent in clinical trial. Methods The human interleukin-2 cDNA containing full-length of encoding region was cloned by RT-PCR and confirmed by DNA sequencing. With recombinant PCR, authors amplified the whole genes of IL-2 with the site-directed mutagenesis and confirmed by DNA sequencing again, then cloned to the procaryotic expressive vector pGEX-4T-2 and transformated to E.coli.DH5 IL-2 recombinant clone was induced by IPTG to express the allosteric IL-2 proteins and the products were identified by SDS-PAGEPAGE.Results The mutated IL-2 gene clone was obtained successfully, while the recom-binant IL-2 proteins were efficiently expressed in E.coli DH5 Human IL-2 cDNA with the site-directed mutagenesis were expressed in E.coli, which has provided useful information for development of low-toxic, high-efficiency IL-2 recombinant agent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To construct expression clones of a site-specific mutagenesis(88N→R) of human interleukin-2(IL-2) gene to further investigate new kind of hIL-2 gene agent in clinical trial. Methods The human interleukin-2 cDNA containing full-length of encoding region was cloned by RT-PCR and confirmed by DNA sequencing. With recombinant PCR, authors amplified the whole genes of IL-2 with the site-directed mutagenesis and confirmed by DNA sequencing again, then cloned to the procaryotic expressive vector pGEX-4T-2 and transformated to E.coli.DH5 IL-2 recombinant clone was induced by IPTG to express the allosteric IL-2 proteins and the products were identified by SDS-PAGEPAGE.Results The mutated IL-2 gene clone was obtained successfully, while the recom-binant IL-2 proteins were efficiently expressed in E.coli DH5 Human IL-2 cDNA with the site-directed mutagenesis were expressed in E.coli, which has provided useful information for development of low-toxic, high-efficiency IL-2 recombinant agent.

Key concepts: Recombinant DNA, Mutagenesis, Complementary DNA, Gene, Molecular biology, Site-directed mutagenesis, Biology, Mutant

Related papers

Back to paper searchBrowse research topicsOriginal source
Construction and expression of a site-specific mutant of human interleukin-2 gene in E.coli — Research Paper | ScholarLens